3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
179
Lung Neoplasms
60
Neoplasms
24
Neoplasm Metastasis
17
Parkinson Disease 4, Autosomal Dominant Lewy Body
13
Mesothelioma, Malignant
12
Carcinoma
12
Colorectal Neoplasms
10
Mesothelioma
9
Meningeal Carcinomatosis
8
Melanoma
7
Brain Neoplasms
7
Adenocarcinoma of Lung
7
Pancreatic Neoplasms
6
Advanced Solid Tumors
5
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
4
Neoplasms by Site
4
NSCLC
4
Colonic Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Non-squamous Non-small Cell Lung Cancer
3
Neoplasms by Histologic Type
3
Lung Diseases
3
Head and Neck Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Bronchogenic
3
Adenocarcinoma
3
Thoracic Neoplasms
2
Interventions
Cisplatin
26
Paclitaxel
21
pembrolizumab
15
Radiotherapy
13
Carboplatin
13
tislelizumab
12
Fluorouracil
12
Drug Therapy
11
Irinotecan
9
toripalimab
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Neoadjuvant Therapy
5
Leucovorin
5
Docetaxel
5
lenvatinib
4
camrelizumab
4
Taxes
4
Radiation
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
spartalizumab
3
sintilimab
3
apatinib
3
Itraconazole
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Pemetrexed
×
1 year
×
Clear all
No trials found.